<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 07 Jul 2026 10:27:44 -0400--><rss version="2.0">
    <channel>
        <title>Immunovant, Inc. (IMVT) SEC Filings</title>
        <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/rss</link>
        <description>Immunovant, Inc. (IMVT) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_d6ae8ad1fc90c30ceeec0c8ff3e3b1be/immunovant/files/theme/images/logo-sm.jpg</url>
                <title>Immunovant, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000077/0001764013-26-000077.pdf</link>
                <pubDate>Mon, 06 Jul 26 17:01:55 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000077/0001764013-26-000077.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000075/0001764013-26-000075.pdf</link>
                <pubDate>Fri, 26 Jun 26 19:47:17 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000075/0001764013-26-000075.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000074/0001764013-26-000074.pdf</link>
                <pubDate>Fri, 26 Jun 26 19:46:26 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000074/0001764013-26-000074.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000073/0001764013-26-000073.pdf</link>
                <pubDate>Fri, 26 Jun 26 19:45:35 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000073/0001764013-26-000073.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000072/0001764013-26-000072.pdf</link>
                <pubDate>Fri, 26 Jun 26 19:44:29 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000072/0001764013-26-000072.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000071/0001764013-26-000071.pdf</link>
                <pubDate>Fri, 26 Jun 26 19:43:43 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000071/0001764013-26-000071.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-006543/0001950047-26-006543.pdf</link>
                <pubDate>Fri, 26 Jun 26 16:25:48 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-006543/0001950047-26-006543.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-006532/0001950047-26-006532.pdf</link>
                <pubDate>Fri, 26 Jun 26 16:23:26 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-006532/0001950047-26-006532.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-006531/0001950047-26-006531.pdf</link>
                <pubDate>Fri, 26 Jun 26 16:21:46 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-006531/0001950047-26-006531.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-006530/0001950047-26-006530.pdf</link>
                <pubDate>Fri, 26 Jun 26 16:21:09 -0400</pubDate>
                <guid>https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-006530/0001950047-26-006530.pdf</guid>
                                                                            </item>
            </channel>
</rss>